Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis

Fig. 2

Hazard ratios (HR) and 95 % confidence intervals for overall survival of patients with lung a or breast b cancer. HR was calculated by adjusting for cancer stage, performance status, comorbidity index, and age at the time of cancer diagnosis. HR for lung cancer was adjusted also for the presence of ILD. ND, not determined; DM, dermatomyositis; PM, polymyositis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SSc, systemic sclerosis

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us